The new Dr. Oligo 48
Since 2015, Biolytic Lab Performance’s Dr. Oligo 48 has been one of the industry‘s
top
performing medium throughput oligo
synthesizer on the market. We are proud to introduce the new Dr.
Oligo 48, our latest innovation in
medium throughput oligo synthesis.
Now with more reagent capability than ever before - a
record high of 42 total reagents
(4 base amidites, 6 standard synthesis reagents and up to 32 special amidites) - the new
Dr. Oligo
48 will expand the limits
of your molecule synthesis and experimental potential.
For over 25 years, laboratories all over the world have been using nucleic acids
produced by
our Dr. Oligo synthesizers for their
own exciting applications. Many of our customers are focused on diagnostic and
therapeutic applications for various viruses, diseases and conditions where DNA and RNA
are a critical piece of their overall products and services.
Such applications include gene synthesis, genetic diagnostic test kits, PCR/RT-PCR,
siRNA,/RNAi,
miRNA, CRISPR Cas9, anti-sense treatments and DNA/RNA sequencing - to broader areas
like evolutionary history, forensics, immunotherapy, diagnostic and therapeutic research
-
to high-throughput screening, modified oligos, mixed backbones, LNAs, and
the visual detection of virus RNA such as COVID-19 following RT-LAMP amplification
with DNA primers.
The new Dr. Oligo 48 increases the number of specials from 18 to a maximum of 32,
potentially adding large degrees of complexities in the sequences to be synthesized
in a single run. The new Dr. Oligo 48 can be used to synthesize DNA, RNA, LNA,
morpholino
oligos, chimeric oligos, 2-'Omethyl RNA, phosphorothioate oligos, bridge nucleic acids
(BNA),
antisense oligos, threose nucleic acids (TNA), glycol nucleic acids (GNA), XNA molecules
and various other mixed oligos.
